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Pleiotropy refers to a single genetic locus having multiple phenotypic effects.  Evidence of pleiotropy 
can suggest shared molecular mechanisms or disease susceptibility pathways between 
phenotypes.  Several regions of the genome demonstrate pleiotropic effects with multiple cancers, 
but the extent of these pleiotropic relationships has not been fully characterized.  To identify 
pleiotropic genetic variants that may impact melanoma risk, Drs. Jonathan Kocarnik and Ulrike 
Peters and colleagues in the Public Health Sciences Division evaluated a panel of genetic variants 
previously associated with other cancers for an association with melanoma.  As recently reported 
in PLoS One, the authors provided confirmatory evidence of such an association for two variants, 
while also providing additional suggestive evidence for a third variant that may have a male-specific 
effect. 
Melanoma is the most serious form of skin cancer.  While the largest risk factor for melanoma is 
ultraviolet radiation exposure, several genetic variants have also been found to impact risk.  Many of 
these variants are expected to affect melanoma risk through their impact on pigmentation.  By 
looking for pleiotropic associations with genetic variants associated with other cancers, additional 
mechanisms of melanoma susceptibility may be identified.  
As such, the authors evaluated 181 single nucleotide polymorphisms (SNPs) associated with various 
cancers for an additional association with melanoma.  For each SNP, the authors performed meta-
analyses across five studies, totaling over 2,000 melanoma cases and 20,000 controls.  Three of 
these studies were participants in the Population Architecture using Genomics and Epidemiology 
(PAGE) study, while the other two were collaborating cohort studies of health professionals.  
From these analyses, the authors found two SNPs associated with melanoma after correction for 
multiple comparisons.  These variants are located in the TERT/CLPTM1L locus, a well-known 
pleiotropic region that has been associated with several cancers, including melanoma and lung 
cancer.  Similar to previous findings, these variants previously associated with an increased risk of 
lung cancer were also found to be associated with a decreased risk of melanoma.  "These 
pleiotropic effects in opposite directions are interesting not only from the standpoint of elucidating  
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tumor biology," said lead author Dr. Kocarnik, "but also from a risk interpretation and communication 
standpoint."  Whereas most genetic variants are generally thought of as only impacting risk for one 
phenotype or only increasing or decreasing risk, pleiotropic variants such as these will require a 
more nuanced understanding and discussion.  
Because previous melanoma studies have shown sex differences in anatomical location, risk of 
metastases, and survival, the authors also performed analyses stratified by sex.  One additional 
variant, a prostate cancer SNP between TPCN2 and MYEOV, showed a suggestive association with 
melanoma in males but not in females.  While not reaching statistical significance after multiple 
comparisons adjustment, several lines of evidence offer biological plausibility for the finding.  Two 
coding variants in the ion channel gene TPCN2 have been associated with hair pigmentation, 
while MYEOV is an oncogene that includes variants implicated for multiple cancers.  
The authors had previously reported a sex difference in the association with melanoma for another 
SNP in a solute-carrier gene associated with pigmentation.  Other studies have demonstrated the 
functional importance of ion and small molecule transport to melanogenesis and the pigmentation 
pathway, and that these processes can be up or down regulated by sex hormones.  "Together with 
our sex-specific findings, these lines of evidence raise questions regarding potential sex differences 
in the relationships between ion transport, pigmentation, and melanoma risk," said Dr. Kocarnik.  "It 
is possible that sex differences in circulating levels of these hormones impact ion exchange or 
tyrosinase activity in a way that modifies the effect of these variants on melanoma risk, perhaps 
through alterations to melanogenesis or skin pigmentation."  Future research will be needed to 
further explore these potential relationships. 
Other Public Health Sciences Division researchers contributing to this project were Drs. Chris 
Carlson and Charles Kooperberg. 
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Image from the publication. 
This pleiotropy-colored Manhattan plot shows the –log(10) p-value 
for the association between melanoma and SNPs previously 
associated with other cancers. The solid line denotes the 
Bonferroni-corrected significance threshold for this analysis 
(0.05/181 SNPs). 
 
